AMRX
HealthcareAmneal Pharmaceuticals, Inc.
$12.40-0.03 (-0.20%)
Prev Close
$12.43
Open
$12.35
High
$12.54
Low
$12.22
Volume
998.3K
Market Cap
$4.13B
P/E
51.20
Div Yield
—
Over the past 12 months, insider activity at Amneal Pharmaceuticals, Inc. (AMRX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 16 insider sales totaling $15.22M. The most recent insider transaction was by Nark Ted C (Director), who sold $586.0K worth of shares on Nov 17, 2025. Amneal Pharmaceuticals, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $4.13B.
Buys (12M)
0
$0.00
Sells (12M)
16
$15.22M
Net Activity
Net Seller
$15.22M
Active Insiders
7
last 12 mo
AMRX Price Chart
AMRX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025↗ | Nark Ted C | Director | Sell | 50,000 | $11.72 | $586.0K | 0 |
| Nov 12, 2025↗ | Shah Nikita | Executive Vice President | Sell | 131,856 | $11.92 | $1.57M | 0 |
| Aug 27, 2025↗ | Kiely John | Director | Sell | 32,000 | $9.23 | $295.4K | 0 |
| Aug 22, 2025↗ | Shah Nikita | Executive Vice President | Sell | 120,832 | $9.65 | $1.17M | 0 |
| Aug 20, 2025↗ | BOYER ANDREW S | Executive Vice President | Sell | 279,244 | $9.38 | $2.62M | 0 |
| Aug 14, 2025↗ | Shah Nikita | Executive Vice President | Sell | 71,694 | $9.29 | $666.0K | 0 |
| Aug 13, 2025↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 499,730 | $9.33 | $4.66M | 0 |
| Aug 12, 2025↗ | BOYER ANDREW S | Executive Vice President | Sell | 33,436 | $9.05 | $302.6K | 0 |
| Aug 12, 2025↗ | Daly Jason B. | EVP, Chief Legal Officer | Sell | 22,000 | $9.05 | $199.1K | 0 |
| Aug 12, 2025↗ | Shah Nikita | Executive Vice President | Sell | 50,000 | $9.04 | $452.0K | 0 |
| Jun 16, 2025↗ | Patel Gautam | Director | Sell | 94,906 | $8.02 | $761.1K | 0 |
| Jun 10, 2025↗ | Patel Gautam | Director | Sell | 56,426 | $8.02 | $452.5K | 0 |
| May 16, 2025↗ | Shah Nikita | Executive Vice President | Sell | 49,140 | $7.58 | $372.5K | 0 |
| May 12, 2025↗ | Kiely John | Director | Sell | 50,000 | $7.59 | $379.5K | 0 |
| May 2, 2025↗ | Patel Gautam | Director | Sell | 8,668 | $8.00 | $69.3K | 0 |
| Apr 1, 2025↗ | Patel Gautam | Director | Sell | 80,000 | $8.30 | $664.0K | 0 |
| Mar 14, 2025↗ | Patel Tushar Bhikhubhai | 10% Owner | Sell | 5,000,000 | $8.35 | $41.75M | 0 |
| Mar 5, 2025↗ | Alva Emily Peterson | Director | Sell | 80,000 | $8.90 | $712.0K | 0 |
| Mar 5, 2025↗ | BOYER ANDREW S | Executive Vice President | Sell | 125,000 | $8.89 | $1.11M | 0 |
| Mar 5, 2025↗ | Daly Jason B. | EVP, Chief Legal Officer | Sell | 90,000 | $8.80 | $792.2K | 0 |
| Mar 5, 2025↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 100,000 | $8.91 | $891.0K | 0 |
| Mar 3, 2025↗ | BOYER ANDREW S | Executive Vice President | Sell | 145,342 | $8.77 | $1.27M | 0 |
| Mar 3, 2025↗ | Daly Jason B. | EVP, Chief Legal Officer | Sell | 64,724 | $8.78 | $568.2K | 0 |
| Mar 3, 2025↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 155,907 | $8.77 | $1.37M | 0 |
| Mar 3, 2025↗ | Patel Chintu | Co-CEO | Sell | 320,835 | $8.77 | $2.81M | 0 |
| Mar 3, 2025↗ | Patel Chirag K. | President & Co-CEO | Sell | 326,888 | $8.77 | $2.87M | 0 |
| Mar 3, 2025↗ | Patel Gautam | Director | Sell | 80,000 | $8.90 | $712.0K | 0 |
| Mar 3, 2025↗ | Shah Nikita | Executive Vice President | Sell | 134,481 | $8.77 | $1.18M | 0 |
| Mar 1, 2025↗ | BOYER ANDREW S | Executive Vice President | Sell | 11,737 | $8.67 | $101.8K | 0 |
| Mar 1, 2025↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 13,494 | $8.67 | $117.0K | 0 |
| Mar 1, 2025↗ | Shah Nikita | Executive Vice President | Sell | 10,985 | $8.67 | $95.2K | 0 |
| Feb 3, 2025↗ | Patel Gautam | Director | Sell | 80,000 | $8.14 | $651.2K | 0 |
| Jan 8, 2025↗ | Patel Gautam | Director | Sell | 62,590 | $8.01 | $501.3K | 0 |
| Jan 2, 2025↗ | Patel Gautam | Director | Sell | 17,410 | $8.01 | $139.5K | 0 |
| Nov 22, 2024↗ | Kiely John | Director | Sell | 17,058 | $8.38 | $142.9K | 0 |
| Nov 21, 2024↗ | Autor Deborah M. | Director | Sell | 40,000 | $8.35 | $334.1K | 0 |
| Nov 21, 2024↗ | Daly Jason B. | SVP, Chief Legal Officer | Sell | 13,665 | $8.40 | $114.8K | 0 |
| Nov 15, 2024↗ | Daly Jason B. | SVP, Chief Legal Officer | Sell | 43,657 | $8.61 | $375.9K | 0 |
| Aug 14, 2024↗ | BOYER ANDREW S | Executive Vice President | Sell | 62,711 | $7.84 | $491.4K | 0 |
| Aug 14, 2024↗ | Shah Nikita | Executive Vice President | Sell | 100,000 | $7.75 | $775.0K | 0 |
| May 16, 2024↗ | Autor Deborah M. | Director | Sell | 38,000 | $6.74 | $256.1K | 0 |
| Mar 12, 2024↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 30,790 | $5.31 | $163.5K | 0 |
| Mar 3, 2024↗ | Daly Jason B. | SVP, Chief Legal Officer | Sell | 18,030 | $5.47 | $98.6K | 0 |
| Mar 1, 2024↗ | BOYER ANDREW S | Executive Vice President | Sell | 60,781 | $5.47 | $332.5K | 0 |
| Mar 1, 2024↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 49,280 | $5.47 | $269.6K | 0 |
| Mar 1, 2024↗ | Shah Nikita | Executive Vice President | Sell | 56,316 | $5.47 | $308.0K | 0 |
| Feb 27, 2024↗ | BOYER ANDREW S | Executive Vice President | Sell | 16,556 | $5.71 | $94.5K | 0 |
| Feb 27, 2024↗ | Shah Nikita | Executive Vice President | Sell | 18,670 | $5.71 | $106.6K | 0 |
| Aug 11, 2023↗ | BOYER ANDREW S | Executive Vice President | Sell | 29,302 | $4.13 | $120.9K | 0 |
| Jun 30, 2023↗ | BOYER ANDREW S | Executive Vice President | Sell | 11,571 | $3.10 | $35.9K | 0 |
Showing 1–50 of 81
1 / 2
AMRX Insider Buying Activity
The following table shows recent insider purchases of Amneal Pharmaceuticals, Inc. (AMRX) stock reported via SEC Form 4 filings.
No insider buying activity found for AMRX in the last 12 months.
AMRX Insider Selling Activity
The following table shows recent insider sales of Amneal Pharmaceuticals, Inc. (AMRX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025↗ | Nark Ted C | Director | Sell | 50,000 | $11.72 | $586.0K | 0 |
| Nov 12, 2025↗ | Shah Nikita | Executive Vice President | Sell | 131,856 | $11.92 | $1.57M | 0 |
| Aug 27, 2025↗ | Kiely John | Director | Sell | 32,000 | $9.23 | $295.4K | 0 |
| Aug 22, 2025↗ | Shah Nikita | Executive Vice President | Sell | 120,832 | $9.65 | $1.17M | 0 |
| Aug 20, 2025↗ | BOYER ANDREW S | Executive Vice President | Sell | 279,244 | $9.38 | $2.62M | 0 |
| Aug 14, 2025↗ | Shah Nikita | Executive Vice President | Sell | 71,694 | $9.29 | $666.0K | 0 |
| Aug 13, 2025↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 499,730 | $9.33 | $4.66M | 0 |
| Aug 12, 2025↗ | BOYER ANDREW S | Executive Vice President | Sell | 33,436 | $9.05 | $302.6K | 0 |
| Aug 12, 2025↗ | Daly Jason B. | EVP, Chief Legal Officer | Sell | 22,000 | $9.05 | $199.1K | 0 |
| Aug 12, 2025↗ | Shah Nikita | Executive Vice President | Sell | 50,000 | $9.04 | $452.0K | 0 |
| Jun 16, 2025↗ | Patel Gautam | Director | Sell | 94,906 | $8.02 | $761.1K | 0 |
| Jun 10, 2025↗ | Patel Gautam | Director | Sell | 56,426 | $8.02 | $452.5K | 0 |
| May 16, 2025↗ | Shah Nikita | Executive Vice President | Sell | 49,140 | $7.58 | $372.5K | 0 |
| May 12, 2025↗ | Kiely John | Director | Sell | 50,000 | $7.59 | $379.5K | 0 |
| May 2, 2025↗ | Patel Gautam | Director | Sell | 8,668 | $8.00 | $69.3K | 0 |
| Apr 1, 2025↗ | Patel Gautam | Director | Sell | 80,000 | $8.30 | $664.0K | 0 |
| Mar 14, 2025↗ | Patel Tushar Bhikhubhai | 10% Owner | Sell | 5,000,000 | $8.35 | $41.75M | 0 |
| Mar 5, 2025↗ | Alva Emily Peterson | Director | Sell | 80,000 | $8.90 | $712.0K | 0 |
| Mar 5, 2025↗ | BOYER ANDREW S | Executive Vice President | Sell | 125,000 | $8.89 | $1.11M | 0 |
| Mar 5, 2025↗ | Daly Jason B. | EVP, Chief Legal Officer | Sell | 90,000 | $8.80 | $792.2K | 0 |
| Mar 5, 2025↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 100,000 | $8.91 | $891.0K | 0 |
| Mar 3, 2025↗ | BOYER ANDREW S | Executive Vice President | Sell | 145,342 | $8.77 | $1.27M | 0 |
| Mar 3, 2025↗ | Daly Jason B. | EVP, Chief Legal Officer | Sell | 64,724 | $8.78 | $568.2K | 0 |
| Mar 3, 2025↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 155,907 | $8.77 | $1.37M | 0 |
| Mar 3, 2025↗ | Patel Chintu | Co-CEO | Sell | 320,835 | $8.77 | $2.81M | 0 |
| Mar 3, 2025↗ | Patel Chirag K. | President & Co-CEO | Sell | 326,888 | $8.77 | $2.87M | 0 |
| Mar 3, 2025↗ | Patel Gautam | Director | Sell | 80,000 | $8.90 | $712.0K | 0 |
| Mar 3, 2025↗ | Shah Nikita | Executive Vice President | Sell | 134,481 | $8.77 | $1.18M | 0 |
| Mar 1, 2025↗ | BOYER ANDREW S | Executive Vice President | Sell | 11,737 | $8.67 | $101.8K | 0 |
| Mar 1, 2025↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 13,494 | $8.67 | $117.0K | 0 |
| Mar 1, 2025↗ | Shah Nikita | Executive Vice President | Sell | 10,985 | $8.67 | $95.2K | 0 |
| Feb 3, 2025↗ | Patel Gautam | Director | Sell | 80,000 | $8.14 | $651.2K | 0 |
| Jan 8, 2025↗ | Patel Gautam | Director | Sell | 62,590 | $8.01 | $501.3K | 0 |
| Jan 2, 2025↗ | Patel Gautam | Director | Sell | 17,410 | $8.01 | $139.5K | 0 |
| Nov 22, 2024↗ | Kiely John | Director | Sell | 17,058 | $8.38 | $142.9K | 0 |
| Nov 21, 2024↗ | Autor Deborah M. | Director | Sell | 40,000 | $8.35 | $334.1K | 0 |
| Nov 21, 2024↗ | Daly Jason B. | SVP, Chief Legal Officer | Sell | 13,665 | $8.40 | $114.8K | 0 |
| Nov 15, 2024↗ | Daly Jason B. | SVP, Chief Legal Officer | Sell | 43,657 | $8.61 | $375.9K | 0 |
| Aug 14, 2024↗ | BOYER ANDREW S | Executive Vice President | Sell | 62,711 | $7.84 | $491.4K | 0 |
| Aug 14, 2024↗ | Shah Nikita | Executive Vice President | Sell | 100,000 | $7.75 | $775.0K | 0 |
| May 16, 2024↗ | Autor Deborah M. | Director | Sell | 38,000 | $6.74 | $256.1K | 0 |
| Mar 12, 2024↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 30,790 | $5.31 | $163.5K | 0 |
| Mar 3, 2024↗ | Daly Jason B. | SVP, Chief Legal Officer | Sell | 18,030 | $5.47 | $98.6K | 0 |
| Mar 1, 2024↗ | BOYER ANDREW S | Executive Vice President | Sell | 60,781 | $5.47 | $332.5K | 0 |
| Mar 1, 2024↗ | Konidaris Tasos | Executive Vice President & CFO | Sell | 49,280 | $5.47 | $269.6K | 0 |
| Mar 1, 2024↗ | Shah Nikita | Executive Vice President | Sell | 56,316 | $5.47 | $308.0K | 0 |
| Feb 27, 2024↗ | BOYER ANDREW S | Executive Vice President | Sell | 16,556 | $5.71 | $94.5K | 0 |
| Feb 27, 2024↗ | Shah Nikita | Executive Vice President | Sell | 18,670 | $5.71 | $106.6K | 0 |
| Aug 11, 2023↗ | BOYER ANDREW S | Executive Vice President | Sell | 29,302 | $4.13 | $120.9K | 0 |
| Jun 30, 2023↗ | BOYER ANDREW S | Executive Vice President | Sell | 11,571 | $3.10 | $35.9K | 0 |
AMRX Insiders
Similar Stocks to AMRX
ZTS
Zoetis Inc.
$118.03-3.00%
$50.88B
VTRS
Viatris Inc.
$13.76-0.33%
$15.56B
NBIX
Neurocrine Biosciences, Inc.
$130.43-0.21%
$13.03B
INDV
Indivior Pharmaceuticals Inc
$30.71-1.98%
$4.05B
SUPN
Supernus Pharmaceuticals, Inc.
$49.42-2.74%
$3.08B
PAHC
Phibro Animal Health Corporation
$52.35-0.30%
$1.95B
ANIP
ANI Pharmaceuticals, Inc.
$74.50+0.13%
$1.68B
PRGO
Perrigo Company plc
$9.95-3.45%
$1.39B